Evidence map›Paper›PMID 35137788›Full record

ArticleArquivos brasileiros de cardiologia2022

Screening for Familial Hypercholesterolemia in Small Towns: Experience from 11 Brazilian Towns in the Hipercolbrasil Program.

Cinthia Elim Jannes, Júnea Paolucci Paiva Silvino, Pãmela Rodrigues de Souza Silva, Isabella Ramos Lima, Mauricio Teruo Tada, Theo Gremen Mimary Oliveira, Raul D Santos, José Eduardo Krieger, Alexandre da Costa Pereira

Abstract read
In one paragraph

Article in Arquivos brasileiros de cardiologia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Extracellular vesicles related to familial hypercholesterolemia.Archives of endocrinology and metabolism · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Cinthia Elim JannesUniversidade de São Paulo Instituto do Coração - Laboratório de Genética e Cardiologia Molecular, São Paulo, SP - Brasil.ORCID 0000-0002-8791-642X
Júnea Paolucci Paiva SilvinoUniversidade Federal de Minas Gerais - Faculdade de Medicina, Belo Horizonte, MG - Brasil.
Pãmela Rodrigues de Souza SilvaUniversidade Federal de Mato Grosso - Faculdade de Farmácia, Cuiabá, MS - Brasil.ORCID 0000-0002-3602-603X
Isabella Ramos LimaUniversidade de São Paulo Instituto do Coração - Laboratório de Genética e Cardiologia Molecular, São Paulo, SP - Brasil.
Mauricio Teruo TadaUniversidade de São Paulo Instituto do Coração - Laboratório de Genética e Cardiologia Molecular, São Paulo, SP - Brasil.
Theo Gremen Mimary OliveiraUniversidade de São Paulo Faculdade de Medicina - Instituto do Coração, São Paulo, SP - Brasil.
Raul D SantosHospital Israelita Albert Einstein Ringgold, São Paulo, SP - Brasil.
José Eduardo KriegerUniversidade de São Paulo Instituto do Coração - Laboratório de Genética e Cardiologia Molecular, São Paulo, SP - Brasil.
Alexandre da Costa PereiraUniversidade de São Paulo Instituto do Coração - Laboratório de Genética e Cardiologia Molecular, São Paulo, SP - Brasil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFamilial hypercholesterolemia (FH) is a genetic disease characterized by elevated serum levels of low-density lipoprotein cholesterol (LDL-C), and it is associated with the occurrence of early cardiovascular disease. In Brazil, HipercolBrasil, which is currently the largest FH cascade screening program, has already identified more than 2000 individuals with causal genetic variants for FH. The standard approach is based on cascade screening of referred index cases, individuals with hypercholesterolemia and clinical suspicion of FH.

objectivesTo perform targeted screening of 11 small Brazilian cities with a suspected high prevalence of people with FH.

methodsThe selection of cities occurred in 3 ways: 1) cities in which a founder effect was suspected (4 cities); 2) cities in a region with high rates of early myocardial infarction as described by the National Health System database (2 cities); and 3) cities that are geographically close to other cities with a high prevalence of individuals with FH (5 cities). Statistical significance was considered as p value < 0.05.

resultsOne hundred and five index cases and 409 first-degree relatives were enrolled. The yield of such approach of 4.67 relatives per index case was significantly better (p < 0.0001) than the general HipercolBrasil rate (1.59). We identified 36 IC with a pathogenic or likely pathogenic variant for FH and 240 affected first-degree relatives.

conclusionOur data suggest that, once detected, specific geographical regions warrant a target approach for identification of clusters of individuals with FH.

Indexed as

Hyperlipoproteinemia Type IIBrazilCholesterol, LDLCitiesHumansRisk FactorsCholesterol, LDL

Identifiers

PMID35137788
PMCPMC9007005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.